Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Case Reports in Rheumatology
Volume 2014, Article ID 458231, 4 pages
http://dx.doi.org/10.1155/2014/458231
Case Report

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

1Department of Internal Medicine, Pitié-Salpetrière Hospital Group, 47-83 Boulevard de l’Hôpital, 75013 Paris, France
2Octapharma, 92100 Boulogne-Billancourt, France
3Clinique Mutualiste Catalane, 66000 Perpignan, France

Received 14 May 2014; Revised 9 July 2014; Accepted 10 July 2014; Published 16 July 2014

Academic Editor: Masataka Kuwana

Copyright © 2014 Cherin Patrick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Cherin Patrick, Delain Jean-Christophe, Crave Jean-Charles, and Cartry Odile, “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis,” Case Reports in Rheumatology, vol. 2014, Article ID 458231, 4 pages, 2014. https://doi.org/10.1155/2014/458231.